Mead Johnson Nutrition Company (MJN) : Mondays money flow analysis of Mead Johnson Nutrition Company (MJN) indicates the selling of stock on the strength of price. The investors sold the stock on every rise as seen in the downtick transactions of $1.26 million. In comparison, the inflow of money on upticks was a meager $0.31 million. The dollar value of composite uptick trades minus the downtick trades was negative $0.95 million. The uptick to downtick ratio of 0.25 in the money flow shows weakness. The downtick transaction value was high at $1.12 million, which denotes distribution on strength.. Hence, the net money flow in the stock was negative ($1.12 million). Mead Johnson Nutrition Company (MJN) gained $0.04 at $91.42, a change of 0.04% over the previous days close.
Mead Johnson Nutrition Company is up 8.78% in the last 3-month period. Year-to-Date the stock performance stands at 16.72%. Shares of Mead Johnson Nutrition Company rose by 1.59% in the last five trading days and 6.94% for the last 4 weeks. In a related news, Stratton Christoper Richard, officer (SVP and President, Asia) of Mead Johnson Nutrition Co, unloaded 33,730 shares at an average price of $86.68 on May 2, 2016. The total amount of the transaction was worth $2,923,716, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Mead Johnson Nutrition Company (NYSE:MJN): On Mondays trading session , Opening price of the stock was $91.13 with an intraday high of $91.59. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $90.74. However, the stock managed to close at $91.2, a loss of 0.20% for the day. On the previous day, the stock had closed at $91.38. The total traded volume of the day was 1,024,798 shares.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.